Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-May-21 4:15 PM View:  | Noble James Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 27,492 | -- | -- | (100%) 27.49K to 0 | |
| 07-May-21 4:25 PM View: | Tovey Christopher J. Chief Operating Officer | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 2,496 | -- | -- | (100%) 2.5K to 0 | |
| 07-May-21 4:15 PM View: | Giacobello Scott M. Chief Financial Officer | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 165,108 | -- | -- | (100%) 165.11K to 0 | |
| 07-May-21 4:15 PM View: | Brown Cabot Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 7,200 | -- | -- | (100%) 7.2K to 0 | |
| 07-May-21 4:15 PM View: | MacKey Catherine J Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 10,536 | -- | -- | (100%) 10.54K to 0 | |
| 07-May-21 4:15 PM View: | Secor Alicia Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 10,584 | -- | -- | (100%) 10.58K to 0 | |
| 07-May-21 4:15 PM View: | Guy Geoffrey W Dr Executive Chairman Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 4,781,520 | -- | -- | (97%) 4.91M to 128.93K | |
| 07-May-21 4:15 PM View: | Snyder Douglas B. Chief Legal Officer | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 61,848 | -- | -- | (100%) 61.85K to 0 | |
| 07-May-21 4:15 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 222,773 | -- | -- | (9%) 2.55M to 2.32M | |
| 07-May-21 4:15 PM View: | Knappertz Volker Chief Medical Officer | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 92,412 | -- | -- | (100%) 92.41K to 0 | |
| 07-May-21 4:15 PM View: | Guy Geoffrey W Dr Executive Chairman Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 128,925 | -- | -- | (100%) 128.93K to 0 | |
| 07-May-21 4:21 PM View: | Cline Darren S U.S. Chief Commercial Officer | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 5,556 | -- | -- | (100%) 5.56K to 0 | |
| 07-May-21 4:15 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 2,323,360 | -- | -- | (100%) 2.32M to 0 | |
| 30-Mar-21 8:00 PM View: | Knappertz Volker Director | Gw Pharmaceuticals Plc (GWPH) | 26-Mar-21 | Sale | 3,060 | $18.10 | $55,386.00 | (3%) 95.47K to 92.41K | |
| 08-Apr-21 8:00 PM View: | Snyder Douglas B. Chief Legal Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Mar-21 | Sale | 8,400 | $18.12 | $152,208.00 | (12%) 70.25K to 61.85K | |
| 22-Mar-21 8:00 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 19-Mar-21 | Gift | 276,000 | -- | -- | (13%) 2.14M to 1.87M | |
| 22-Mar-21 8:00 PM View: | Brown Cabot Director | Gw Pharmaceuticals Plc (GWPH) | 18-Mar-21 | Sale | 4,020 | $17.95 | $72,159.00 | (36%) 11.22K to 7.2K | |
| 02-Mar-21 9:43 PM View: | MacKey Catherine J Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 1,260 | $17.85 | $22,491.00 | (11%) 11.8K to 10.54K | |
| 02-Mar-21 9:43 PM View: | MacKey Catherine J Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 3,144 | $0.00 | $4.40 | 36% 8.65K to 11.8K | |
| 02-Mar-21 9:43 PM View: | Secor Alicia Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 1,260 | $17.85 | $22,491.00 | (11%) 11.84K to 10.58K | |
| 02-Mar-21 9:25 PM View: | Giacobello Scott M. Chief Financial Officer | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 3,300 | $17.85 | $58,905.00 | (2%) 168.41K to 165.11K | |
| 02-Mar-21 9:43 PM View: | Secor Alicia Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 3,144 | $0.00 | $4.40 | 36% 8.7K to 11.84K | |
| 02-Mar-21 9:27 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 17,004 | $0.00 | $23.81 | 8% 214.18K to 231.19K | |
| 02-Mar-21 9:42 PM View: | Brown Cabot Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 3,144 | $0.00 | $4.40 | 34% 9.34K to 12.48K | |
| 02-Mar-21 9:31 PM View: | Knappertz Volker Chief Medical Officer | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 2,712 | $17.85 | $48,409.20 | (3%) 98.18K to 95.47K | |
| 02-Mar-21 9:42 PM View: | Snyder Douglas B. Chief Legal Officer | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 3,408 | $17.85 | $60,832.80 | (5%) 73.66K to 70.25K | |
| 02-Mar-21 9:31 PM View: | Knappertz Volker Chief Medical Officer | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 6,864 | $0.00 | $9.61 | 8% 91.32K to 98.18K | |
| 02-Mar-21 9:42 PM View: | Brown Cabot Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 1,260 | $17.85 | $22,491.00 | (10%) 12.48K to 11.22K | |
| 02-Mar-21 9:25 PM View: | Giacobello Scott M. Chief Financial Officer | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 6,288 | $0.00 | $8.80 | 4% 162.12K to 168.41K | |
| 02-Mar-21 9:42 PM View: | Snyder Douglas B. Chief Legal Officer | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 6,636 | $0.00 | $9.29 | 10% 67.02K to 73.66K | |
| 02-Mar-21 9:27 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 8,412 | $17.85 | $150,154.00 | (4%) 231.19K to 222.77K | |
| 02-Mar-21 9:42 PM View: | Snyder Douglas B. Chief Legal Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Payment of Exercise | 70,764 | $17.90 | $1,266,680.00 | (51%) 137.78K to 67.02K | |
| 02-Mar-21 9:31 PM View: | Knappertz Volker Chief Medical Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Option Exercise | 120,996 | $0.00 | $169.39 | 674% 17.94K to 138.94K | |
| 02-Mar-21 9:25 PM View: | Giacobello Scott M. Chief Financial Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Option Exercise | 149,160 | $0.00 | $208.82 | 166% 90.06K to 239.22K | |
| 02-Mar-21 9:42 PM View: | Snyder Douglas B. Chief Legal Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Option Exercise | 137,784 | $0.00 | $192.90 | 100% 0 to 137.78K | |
| 02-Mar-21 9:27 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Payment of Exercise | 208,896 | $17.90 | $3,739,240.00 | (49%) 423.08K to 214.18K | |
| 02-Mar-21 9:25 PM View: | Giacobello Scott M. Chief Financial Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Payment of Exercise | 78,096 | $17.90 | $1,397,920.00 | (33%) 239.22K to 161.12K | |
| 02-Mar-21 9:27 PM View: | Gover Justin D. Chief Executive Officer Director | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Option Exercise | 423,072 | $0.00 | $592.30 | 8461440% 5 to 423.08K | |
| 02-Mar-21 9:31 PM View: | Knappertz Volker Chief Medical Officer | Gw Pharmaceuticals Plc (GWPH) | 26-Feb-21 | Payment of Exercise | 47,616 | $17.90 | $852,326.00 | (34%) 138.94K to 91.32K | |
| 25-Jan-21 7:37 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 22-Jan-21 | Option Exercise | 14,700 | $9.61 | $141,267.00 | 147% 10.0K to 24.7K | |
| 25-Jan-21 7:37 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 22-Jan-21 | Planned Option Sale | 14,700 | $11.69 | $171,843.00 | (60%) 24.7K to 10.0K | |
| 25-Jan-21 7:37 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 21-Jan-21 | Option Exercise | 24,588 | $9.61 | $236,291.00 | 246% 10.0K to 34.59K | |
| 25-Jan-21 7:37 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 21-Jan-21 | Planned Option Sale | 24,588 | $11.69 | $287,518.00 | (71%) 34.59K to 10.0K | |
| 20-Jan-21 8:00 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 19-Jan-21 | Option Exercise | 9,600 | $9.61 | $92,256.00 | 96% 10.0K to 19.6K | |
| 20-Jan-21 8:00 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 19-Jan-21 | Planned Option Sale | 9,600 | $11.68 | $112,128.00 | (49%) 19.6K to 10.0K | |
| 20-Jan-21 8:00 PM View: | Knappertz Volker Chief Medical Officer | Gw Pharmaceuticals Plc (GWPH) | 19-Jan-21 | Sale (Planned) | 6,000 | $11.67 | $70,020.00 | (25%) 23.94K to 17.94K | |
| 20-Jan-21 8:00 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 15-Jan-21 | Option Exercise | 79,860 | $10.06 | $803,683.00 | 799% 10.0K to 89.86K | |
| 20-Jan-21 8:00 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 15-Jan-21 | Planned Option Sale | 79,860 | $11.73 | $936,754.00 | (89%) 89.86K to 10.0K | |
| 15-Jan-21 8:00 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 13-Jan-21 | Option Exercise | 675,744 | $0.37 | $252,710.00 | 6757% 10.0K to 685.74K | |
| 15-Jan-21 8:00 PM View: | George Adam D. Secretary | Gw Pharmaceuticals Plc (GWPH) | 13-Jan-21 | Planned Option Sale | 675,744 | $11.03 | $7,454,010.00 | (99%) 685.74K to 10.0K |
